Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mirela Cerghet

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Journal of the Neurological Sciences|August 11, 2020
The effect of race on clinical presentation and outcomes in neurosarcoidosisMuhammad Affan, Abhimanyu Mahajan, Tooba Rehman, et al.
Journal of Clinical Medicine|September 14, 2024
A Comprehensive Characterization of Patients with Spinal Cord Neurosarcoidosis: A Single Center Cross-Sectional Study of Clinical OutcomesRami Al-Hader, Justin Nofar, Ahmed Mohamedelkhair, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 3, 2006
Proliferation and death of oligodendrocytes and myelin proteins are differentially regulated in male and female rodentsMirela Cerghet, Robert P Skoff, Denise Bessert, et al.
Clinical Neurology and Neurosurgery|July 28, 2022
Clinical and diagnostic spectrum of optic neuritis: A single-center retrospective study of disorders associated with multiple sclerosis, anti-aquaporin-4 and anti-myelin oligodendrocyte glycoprotein antibodiesDana R Siegel, Meredith Van Harn, Meari Taguchi, et al.
Journal of the American Pharmacists Association : Japha|November 21, 2008
Measuring adherence and persistence to disease-modifying agents among patients with relapsing remitting multiple sclerosisJennifer Elston Lafata, Mirela Cerghet, Elizabeth Dobie, et al.
Heliyon|August 22, 2024
Current understanding of cardiovascular autonomic dysfunction in multiple sclerosisInsha Zahoor, Guodong Pan, Mirela Cerghet, et al.
International Journal of Molecular Sciences|June 12, 2026
Longitudinal and Stability-Aware Analysis Reveals Treatment-Specific MicroRNA Response Signatures Following Immune-Reconstitution and B-Cell-Targeted Therapies in Multiple SclerosisNasar Ata, Joshua S Mytych, Mirela Cerghet, et al.
Biorxiv : the Preprint Server for Biology|February 19, 2024
Utility of an untargeted metabolomics approach using a 2D GC-GC-MS platform to distinguish relapsing and progressive multiple sclerosisIndrani Datta, Insha Zahoor, Nasar Ata, et al.
Metabolites|September 27, 2024
Utility of an Untargeted Metabolomics Approach Using a 2D GC-GC-MS Platform to Distinguish Relapsing and Progressive Multiple SclerosisIndrani Datta, Insha Zahoor, Nasar Ata, et al.
Clinical Neurology and Neurosurgery|December 21, 2020
Impairments of white matter tracts and connectivity alterations in five cognitive networks of patients with multiple sclerosisAmirEhsan Lashkari, Esmaeil Davoodi-Bojd, Lara Fahmy, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Journal of the Neurological Sciences|August 11, 2020
The effect of race on clinical presentation and outcomes in neurosarcoidosisMuhammad Affan, Abhimanyu Mahajan, Tooba Rehman, et al.
Journal of Clinical Medicine|September 14, 2024
A Comprehensive Characterization of Patients with Spinal Cord Neurosarcoidosis: A Single Center Cross-Sectional Study of Clinical OutcomesRami Al-Hader, Justin Nofar, Ahmed Mohamedelkhair, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 3, 2006
Proliferation and death of oligodendrocytes and myelin proteins are differentially regulated in male and female rodentsMirela Cerghet, Robert P Skoff, Denise Bessert, et al.
Clinical Neurology and Neurosurgery|July 28, 2022
Clinical and diagnostic spectrum of optic neuritis: A single-center retrospective study of disorders associated with multiple sclerosis, anti-aquaporin-4 and anti-myelin oligodendrocyte glycoprotein antibodiesDana R Siegel, Meredith Van Harn, Meari Taguchi, et al.
Journal of the American Pharmacists Association : Japha|November 21, 2008
Measuring adherence and persistence to disease-modifying agents among patients with relapsing remitting multiple sclerosisJennifer Elston Lafata, Mirela Cerghet, Elizabeth Dobie, et al.
Heliyon|August 22, 2024
Current understanding of cardiovascular autonomic dysfunction in multiple sclerosisInsha Zahoor, Guodong Pan, Mirela Cerghet, et al.
International Journal of Molecular Sciences|June 12, 2026
Longitudinal and Stability-Aware Analysis Reveals Treatment-Specific MicroRNA Response Signatures Following Immune-Reconstitution and B-Cell-Targeted Therapies in Multiple SclerosisNasar Ata, Joshua S Mytych, Mirela Cerghet, et al.
Biorxiv : the Preprint Server for Biology|February 19, 2024
Utility of an untargeted metabolomics approach using a 2D GC-GC-MS platform to distinguish relapsing and progressive multiple sclerosisIndrani Datta, Insha Zahoor, Nasar Ata, et al.
Metabolites|September 27, 2024
Utility of an Untargeted Metabolomics Approach Using a 2D GC-GC-MS Platform to Distinguish Relapsing and Progressive Multiple SclerosisIndrani Datta, Insha Zahoor, Nasar Ata, et al.
Clinical Neurology and Neurosurgery|December 21, 2020
Impairments of white matter tracts and connectivity alterations in five cognitive networks of patients with multiple sclerosisAmirEhsan Lashkari, Esmaeil Davoodi-Bojd, Lara Fahmy, et al.
Pageof 4